Retraction: De novo Cancers following Liver Transplantation: A single center experience in China (PLoS ONE (2014) 9: 1 (e85651) DOI: 10.1371/journal.pone.0085651);De novo cancers following liver transplantation: A single center experience in China

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Yu, Songfeng ^a,b   Gao, Feng ^a,b   Yu, Jun ^a,b   Yan, Sheng ^a,b   Wu, Jian ^a,b   Zhang, Min ^a,b   Wang, Weilin ^a,b   Zheng, Shusen ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KEY LABORATORY OF ORGAN TRANSPLANTATION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ABDOMINAL CANCER; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CADAVER DONOR; CANCER INCIDENCE; CHINA; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; LUNG CANCER; MALE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROME; NASOPHARYNX CANCER; NEOPLASM; PANCREAS CANCER; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; REFRACTORY ANEMIA WITH EXCESS BLASTS; STOMACH CANCER; UTERINE CERVIX CANCER;

ADULT; CHINA; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84899815494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0220430     Document Type: Erratum

References (35)

1. Merion RM (2010) Current status and future of liver transplantation. Semin Liver Dis 30: 411-421.
2. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, et al. (2001) De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7: S109-118.
3. Samuel D, Colombo M, El-Serag H, Sobesky R and Heaton N (2011) Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transpl 17 Suppl 2: S6-13.
4. Baccarani U, Piselli P, Serraino D, Adani GL, Lorenzin D, et al. (2010) Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis 42: 55-60.
5. Sapisochin G, Bilbao I, Dopazo C, Castells L, Lazaro JL, et al. (2011) Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int 5: 707-715.
6. Park HW, Hwang S, Ahn CS, Kim KH, Moon DB, et al. (2012) De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc 44: 802-805.
7. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, et al. (2006) De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant 20: 617-623. (Pubitemid 44383408)
8. Jain A, Fiaz O, Sheikh B, Sharma R, Safadjou S, et al. (2009) Recurrent nonhepatic and de novo malignancies after liver transplantation. Transplantation 88: 706-710.
9. Chatrath H, Berman K, Vuppalanchi R, Slaven J, Kwo P, et al. (2013) De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant 27: 582-590.
10. Ettorre GM, Piselli P, Galatioto L, Rendina M, Nudo F, et al. (2013) De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc 45: 2729-2732.
11. Dantal J and Soulillou JP (2005) Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 352: 1371-1373. (Pubitemid 40411505)
12. Popov Z, Ivanovski O, Kolevski P, Stankov O, Petrovski D, et al. (2007) De novo malignancies after renal transplantation-a single-center experience in the Balkans. Transplant Proc 39: 2589-2591. (Pubitemid 47588387)
13. Chak E and Saab S (2010) Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int 30: 1247-1258.
14. Herrero JI (2009) De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl 15 Suppl 2: S90-94.
15. Chen W, Zheng R and Zhang S (2012) An Analysis of Cancer Incidence in China, 2003-2007. China Cancer 21: 161-170.
16. Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, et al. (2005) De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 11: 89-97. (Pubitemid 40124447)
17. Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, et al. (2013) Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant 13: 174-183.
18. Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, et al. (2012) Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation 94: 990-998.
19. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, et al. (2002) Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 8: 482-487. (Pubitemid 34520778)
20. Kaneko J, Sugawara Y, Tamura S, Aoki T, Sakamoto Y, et al. (2013) De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation 95: 1142-1147.
21. Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, et al. (2004) De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 4: 596-604. (Pubitemid 38523582)
22. Penn I (1994) Depressed immunity and the development of cancer. Cancer Detect Prev 18: 241-252.
23. Euvrard S and Kanitakis J (2006) Skin cancers after liver transplantation: what to do? J Hepatol 44: 27-32. (Pubitemid 41772512)
24. Wimmer CD, Angele MK, Schwarz B, Pratschke S, Rentsch M, et al. (2013) Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Transpl Int 26: 999-1006.
25. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, et al. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1: 583-587. (Pubitemid 14156511)
26. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, et al. (2001) Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34: 84-91. (Pubitemid 32102556)
27. Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, et al. (2001) Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 7: 971-975. (Pubitemid 33085786)
28. Herrero JI, Lucena JF, Quiroga J, Sangro B, Pardo F, et al. (2003) Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 3: 1407-1412. (Pubitemid 37288086)
29. Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, et al. (1997) De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 80: 1141-1150. (Pubitemid 27427615)
30. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, et al. (1998) Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 83: 1237-1243. (Pubitemid 28419079)
31. Menachem Y, Safadi R, Ashur Y and Ilan Y (2003) Malignancy after liver transplantation in patients with premalignant conditions. J Clin Gastroenterol 36: 436-439. (Pubitemid 36459143)
32. Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, et al. (2002) Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 236: 429-436; discussion 436-427.
33. Faria LC, Gigou M, Roque-Afonso AM, Sebagh M, Roche B, et al. (2008) Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 134: 1890-1899; quiz 2155.
34. Chiang YJ, Chen CH, Wu CT, Chu SH, Chen Y, et al. (2004) De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan. Transplant Proc 36: 2150-2151. (Pubitemid 39424360)
35. Zheng SS, Xu X, Wu J, Chen J, Wang WL, et al. (2008) Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85: 1726-1732.